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Abstract 
Background: In treating atrial fibrillation with radio-frequency ablation, few 
studies seek to define a cut-off value for left atrial diameter size beyond which the 
intervention risks outweigh chance of sinus recovery. This study aims to identify a 
cut-off value for pre-operative left atrial diameter to assess the efficacy of surgical 
radio-frequency ablation for treatment of chronic atrial fibrillation in patients 
undergoing mitral valve surgery.  
Methods: A prospective 6-month follow-up cohort study was conducted, in which 
40 patients were recruited during the period from May 2016 till April 2018 at the 
Academy of Cardiothoracic Surgery, Ain Shams University. All patients had either 
isolated mitral valve replacements or mitral valve replacements combined with 
other valve surgeries. A mono-polar saline-irrigated cooled tip Radio-frequency 
ablation (SICTRA) was performed using the Medtronic Radiofrequency Generator 
Model 68000 as an energy source. A voltage of 25-30 watts was adjusted according 
to effectiveness of ablation. Oscillatory and to-and-fro motions were employed on 
the atrial endocardium using the Cardioblate pen until proper blanching or 
whitening was achieved. Receiver operator characteristic (ROC) curves were used 
to calculate the area under the curve and cut-off value for left atrial diameter. The 
efficacy of the overall survival time was estimated using the Kaplan‐Meier method. 
Results: Pre-operatively left atrial diameter of 59 mm was significantly associated 
with decrease in the possibility of reverting to sinus rhythm after surgery (OR 
0.292, p-value = 0.001). The cut-off value for left atrial diameter was 59mm 
(sensitivity = 93.3%, specificity = 96.1%). Kaplan-Meier survival estimates were 
175.07 days (156.3 - 193.9) for patients with left atrial diameter < 59mm and 62.64 
days (26.6-98.7) for patients with left atrial diameter > 59mm.  
Conclusion: In patients undergoing mitral valve, we have experienced a significant 
higher degree of success associated with smaller left atrial diameter (less than 59.0 
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Introduction 
Atrial fibrillation (AF) is the most common 
arrhythmia and a significant cause of morbidity 
such as stroke, thromboembolisms, and heart 
failure [1 – 4]. Extensive research was done in the 
field of methods and techniques treating atrial 
fibrillation. Nowadays, ablation devices are being 
utilized in surgical procedures. Maze procedure 
modifications involved new surgical ablation 
devices using various energy sources. In addition 
to radio-frequency and Cryo-ablation, energy 
sources have included microwave, laser, and 
high-frequency ultrasound [5 – 10]. 
Despite evidence highlighting preoperative 
left atrial diameter (LAD) as a risk factor for maze 
failure, relatively few studies seek to define a 
definitive cut-off value for LAD size beyond which 
the risks of the procedure (such as bleeding, 
infection or stroke) outweigh the chance of sinus 
rhythm (SR) recovery. Some studies have reported 
that, enlarged LAD could be a risk factor for failure 
of a maze procedure. Various models of AF 
suggest that reducing atrial mass and/or diameter 
may help to abolish the re-entry circuits 
underlying AF [10]. However, the evidence is not 
strong since papers available were not readily 
comparable owing to substantial variations in the 
populations and procedures involved [11].  
This study aims to identify a cut-off value for 
the pre-operative LAD to assess the efficacy of 
surgical radio-frequency ablation using unipolar 
pen for the treatment of chronic atrial fibrillation 
in patients undergoing mitral valve surgery (either 
replacement or repair) with or without other 
valvular surgeries.  
Patients and Methods: 
The study was conducted at the Academy of 
cardiothoracic surgery at Ain Shams University, 
Wady El-Nile hospital, Air force specialized 
hospital and Dar El-Salam hospital. Patients were 
recruited during the period from May 2016 till 
April 2018. Demographics and baseline 
measurements were recorded for each patient. All 
patients had rheumatic mitral valve disease with 
or without other valvular disease and permanent 
atrial fibrillation. Permanent AF was defined as 
continuous long-standing AF that lasts for a period 
of more than 12 months and that does not 
respond to electrical or medical cardioversion. 
Routine preoperative investigations were 
preformed which consisted of standard 
preoperative lab work (CBC, coagulation profile, 
and liver and kidney function tests), 12-lead ECG 
strip, transthoracic echocardiography (TTE), 
transesophageal echocardiography (TEE) and 
chest X-Ray. Moreover, anterior-posterior 
diameter was used for measuring the left atrial 
diameter through echocardiography. Other 
inclusion criteria were: both male and female with 
age between 18 and 60 years who underwent 
cardiac surgery of the mitral valve (replacement or 
repair) with or without other valve surgery (aortic, 
tricuspid or combined lesions). Patients with 
chronic kidney failure (CKD) were excluded as CKD 
is often associated with hypertension and high 
atrial pressure, both of which may lead to AF [12]. 
Moreover, patients with chronic liver dysfunction, 
defined as increased circulating levels of γ 
glutamyl transpeptidase and liver transaminase 
markers, increase the risk of new-onset atrial 
fibrillation, thus will be excluded. Ischemic stroke 
patients or patients who had to redo the surgery 
were excluded. Finally, emergency cases were also 
excluded[13,14]. 
Surgical technique
All patients had either isolated mitral valve 
replacements or mitral valve replacements 
combined with other valve surgeries. A median 
sternotomy was employed in all cases after which 
pericardium was then opened using cautery. 
Aortic purse was taken using 3/0 prolene followed 
by atrial purse using 3/0 or 4/0 prolene. In cases 
involving tricuspid valve, tapes were taken around 
SVC and IVC for the right atrial opening 
Cardiopulmonary by-pass was established. The 
conventional approach was used to gain access to 
the mitral valve via left atriotomy [14, 15]. After 
the left atriotomy was done the 4 pulmonary 
veins, the left atrial appendage and the mitral 
valve were clearly defined then the ablation 
procedure started. Then the mitral valve was 
replaced using interrupted sutures on Teflon 
pledges using 2/0 Ethibond. All patients had a left 
atrial maze procedure using radiofrequency 
ablation as an energy source. The procedure was 
performed on the endocardial surface of the heart 
before the actual mitral valve surgery. As shown in 
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Figure 1, monopolar saline-irrigated cooled tip RF 
ablation (SICTRA) was performed using the 
Medtronic Radiofrequency Generator Model 
68000 as an energy source [16]. A voltage of 
25-30 watts was adjusted according to 
effectiveness of ablation. Oscillatory and to-and-
fro motions were employed on the atrial 
endocardium using the Cardioblate pen until 
proper blanching or whitening was achieved. 
Prolonged or repeated application was done 
when necessary in order to achieve a complete 
transmural lesion. After the maze procedure was 
performed closure of the left atrial appendage 
was achieved using a 3-0 polypropylene purse 
string suture or the left atrial appendage were 
included in the ablation lines. After completion of 
surgery and as soon as the patient was weaned 
off cardiopulmonary bypass IV Cordarone therapy 
was administered in the operative theatre and in 
the ICU; first loading dose of 300 mg over 1 hour 
followed by a maintenance dose of 900 mg over 
24 hours. Oral amiodarone administration was 
continued as soon as IV therapy ended through 
the oral route if patient was extubated or 
through a nasogastric tube until extubation. The 
dose was 200 mg once daily for 3 months after 
surgery [9, 13 – 16]. It was important to note that 
none of the patients had excision of the left atrial 
appendage (LAA). 
Post-operative follow-up 
A 12-lead ECG Rhythm strip was done at 1 
week post-operatively and at 3 months while at 6 
months a 24 h Holter was done to view the sinus 
conversion rate. As outlined in the Heart Rhythm 
Society consensus document on AF ablation, 
‘success’ should be defined as freedom from 
symptomatic or ‘asymptomatic’ AF, atrial 
tachycardia, or atrial flutter lasting 30 s or longer 
12 months following AF ablation [16]. A trans-
thoracic echocardiography was performed at 6 
months post-operatively to assess left atrial size, 
ejection fraction and confirm sinus rhythm. The 
incidence of stroke was recorded as well as any 
need for pacemaker implantation. 12-lead ECG 
was recorded on all 4 predetermined times using 
the SCHILLER CARDIOVIT AT-101 ECG. 
Echocardiography was performed by two 
experienced investigators using the GE VIVID 3 
(General Electric) ultrasound device. Values were 
obtained from a mean of 3-5 beats. 
Figure 1: Diagram of the maze lines performed in the 
left atrium. It included pulmonary vein isolation where 
both left pulmonary veins and both right pulmonary 
veins were isolated separately. A roofing line between 
the 2 superior pulmonary veins was done as well two 
lines extending from the left pulmonary vein island, 
one going towards the base of the left atrial 
appendage and the other towards the annulus of the 
mitral valve at a point corresponding to the middle of 
the posterior mitral leaflet. Another blind-ended line 
was drawn perpendicular to the line running from the 
left pulmonary vein island towards the mitral annulus. 
It ran across the isthmus and towards the area of the 
inferior vena cava and stopping just short of the 
atriotomy incision. 
Statistical analysis 
Baseline data were expressed as means with 
standard deviations (SD) or numbers and 
percentages. Evaluation of baseline characteristics 
was done using independent t-tests or Mann-
Whitney U test for continuous variables. Fisher’s 
exact test or chi-square test were used to test the 
significance of association of qualitative variables. 
Univariate logistic regression models were used to 
assess the influence of the measured variables on 
the study outcome. ROC analysis was used to 
detect a cut-off value for the left atrial diameter 
associated with failure to revert to sinus rhythm. 
The Kaplan-Meier method will be used to present 
time to reversion to AF between patients with left 
atrial diameter < 59 mm (Group A) and those with 
higher diameter (Group B), the significance of the 
difference was tested. SPSS software, version 23 
(SPSS Inc., Chicago, Illinois, USA) was used for data 
entry and analysis. All analyses were carried out at 
a 5% two-sided significance level. 
Results 
A total of 40 patients were selected and 
recruited in this prospective cohort study. With no 
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loss to follow-up, all patients successfully 
completed the 3- and 6-month follow-up period 
of the study. Table 1 illustrates baseline 
characteristics for the study cohort. The mitral 
valve was replaced using a metallic prosthesis in 
all cases except two cases were replaced by 
biological valve. Eight cases had Tricuspid valve 
(TV) repair which was done by conventional 
Devega annuloplasty. One case had TV repair by 
Medtronic ring and another case had TV 
replacement. The aortic valve was replaced using 
a metallic prosthesis in all cases. We did not 
experience any of the described procedure-
related complications except for 1 patient who 
presented with a 1st degree heart block for 3 days 
after the procedure and then reverted back to 
sinus rhythm. 
Table 1: Baseline Characteristics 
Baseline Characteristics (n=40) 
Age (mean, SD) in years 47.55 ±7.89 
Duration of Atrial Fibrillation in 
months (mean, SD) 
45.60 ±17.25 
Sex (%) 
Male 12 (30.0) 
Female 28 (70.0) 
Diabetes (%) 
Negative 36 (90.0) 
Positive 4 (10.0) 
Hypertension (%) 
Negative 36 (90.0) 
Positive 4 (10.0) 
Caffeine Intake (%) 
Negative 6 (15.0) 
Positive 34 (85.0) 
Smoking (%) 
Negative 30 (75.0) 
Positive 10 (25.0) 
NYHAa (%) 
2 14 (35.0) 
3 25 (62.5) 
4 1 (2.5) 
a: New York Heart Association heart failure 
Classification  
The mean pre-operative LAD in patients who 
reverted back to sinus rhythm was 50.32 ± 7.22 
while for those who were AF was 64.13 ± 7.11. 
Immediately after surgery, 28 (70%) patients 
returned to sinus rhythm. After 6 month, three 
patients developed AF, leaving a total of 25 
(62.5%) patients with a stable sinus rhythm. The 
results show that pre-operatively LAD (OR 0.292, 
95%CI 0.110 – 0.484, p-value = 0.001) and 
duration of the AF (OR 0.286, 95%CI 0.096 – 0.476, 
p-value = 0.003) was identified to be significantly 
associated with post-operative AF status (Table 
2). 
Receiver operating characteristic (ROC) curves 
were estimated, along with the area under the 
curve (AUC), for the LAD (Figure 2). LAD had an 
AUC of 0.925 (95% CI 0.83 - 0.97, p-value<0.0001). 
At this level, the cut-off value for LAD was 
identified to be 59mm with a corresponding 
Youden index of 0.91, sensitivity was 93.3% (95% 
CI 0.91 - 0.98); specificity was 96.1% (95%CI 0.89 - 
0.98). 
Figure 2: Receiver Operating Characteristics (ROC) 
curve for the left atrial diameter cut-off point. 
For the survival analysis, we experienced right 
censoring in which participants did not have the 
event of interest during the study period (180 
days) and thus their last observed follow-up time 
was less than their time to event. Kaplan-Meier 
survival curves were estimated after using the 
previously selected LAD cut-off value (59.0mm) to 
distribute the study cohort into two groups. Group 
A were patients having a LAD < 59.0mm, while 
group B were patients with a LAD ≥ 59.0mm. 
Figure 3 shows the two survival curves, in which, 
visually, the survival distribution appears to be  
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Table 2: Univariate logistic regression with post-operative AF status as the dependent variable 
Parameter OR a
OR 95% Confidence Interval 
P-value 
Lower Upper 
LAD 0.292 0.110 0.484 0.001* 
Duration of Atrial Fibrillation 0.286 0.096 0.476 0.003* 
Gender 0.811 -0.695 2.317 0.291 
Diabetes -0.571 -2.645 1.504 0.591 
Hypertension -0.571 -2.645 1.504 0.592 
Smoking -0.141 -1.608 1.326 0.855 
Age -0.021 -0.102 0.06 0.613 
Ejection Fraction 0.079 -0.052 0.209 0.237 
Other surgeries 0.118 -1.231 1.467 0.864 
Cross Lamp Time 0.06 -0.037 0.158 0.224 
Bypass Time 0.091 -0.031 0.212 0.143 
NYHA (reference group: Class 4) 
Class 2 1.293 -8.24 8.451 0.931 
Class 3 0.541 -10.24 4.428 0.721 
Surgeries (reference group: Aortic valve replacement) 
Aortic valve replacement 0.377 -1.189 1.944 0.637 
Aortic valve replacement + Tricuspid valve replacement -2.446 -5.83 8.261 0.999 
Tricuspid valve repair 2.178 -5.93 9.402 0.999 
a: Odds ratio for logistic regression models used. 
All hypothesis testing was carried out at the 5% (2-sided) significance level. All p-values were presented with at 
least 3 decimal places.  Significant p-values were noted with an asterisk (*) 
much higher in the Group A (LAD < 59.0mm) 
compared to the Group B (LAD ≥ 59.0mm). There 
was a significant difference in survival times 
between the Group A and Group B (log rank test P-
value = 0.0001). The Kaplan-Meier survival 
probability estimates at 180 Days were about 
175.07 (95% CI 156.26 – 193.89) for Group A and 
62.64 (95% CI 26.59 – 98.69) for Group B (Table 3). 
Discussion 
Patients with mitral valve disease are usually 
diagnosed with concomitant atrial fibrillation (AF) 
which results in a variety of morbidities including 
hemodynamic compromise, syncope, dizziness, 
fatigue, palpitations, chest pain and an increased 
probability of a thromboembolic event [17 – 20]. 
Surgery for treatment of atrial fibrillation 
culminated in the development of Cox-Maze III, 
the Gold standard, which is the procedure with 
the highest success rates [20, 21]. However, it has 
not been widely adopted due to its complexity, 
its need for cardiopulmonary by-pass and its 
significant prolongation of by-pass time. Efforts 
have focused on developing a potentially less 
invasive and less time-consuming operation by 
simplifying the pattern of atrial lesions and using 
alternative energy sources that can create them 
quickly, without a cut-and-sew technique. Intra-
operative endocardial radiofrequency ablation to 
the pulmonary veins for atrial fibrillation is a 
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promising new treatment option for patients with 
atrial fibrillation undergoing cardiac surgery or 
patients with highly symptomatic atrial fibrillation 
not responding to other therapies [22]. The 
evidence suggests that patients with an enlarged 
(≥55.0 mm) or giant (≥75.0 mm) LA who were at 
risk of failing to obtain sinus conversion after a 
standard maze procedure may derive benefit from 
concomitant atrial reduction surgery using either 
a tissue excision or a tissue plication technique 
[11, 13 – 16]. 
Figure 3: Kaplan-Meier Survival curves. Dashes line: 
Group (A) survival curve for Left after diameter < 
59.0mm. Solid line: Group (B) survival curve for Left 
after diameter ≥ 59.0mm. 
In our study, the surgical technique was safe 
with no reported complications such as 
oesophageal perforation, the need for permanent 
pacemaker implantation or PV stenosis. Since our 
mono-polar probe was saline-irrigated atrial wall 
injury, perforation or charring was not observed in 
spite of prolonged ablation time over the same 
areas and the creation of a trans-mural scar was 
much more easily achieved than with dry or 
temperature-controlled RF energy. This further 
affirms safety of the procedure [22, 23]. Also, 
patients in our study had a mean age of 47.55 ± 
7.98; this was largely attributed to the fact that the 
pathology of mitral valve disease in our cases was 
exclusively rheumatic. 
In our study, after 6-month follow-up period, 
25 (62.5%) patients had restored sinus rhythm 
despite rheumatic etiology, large left atrial 
diameters and long AF duration. We employed a 
simple and relatively short procedure that focused 
exclusively on the left atrium taking into account 
the main lines of the maze operation. This finding 
was close to a previous study, were the 
percentage of patients in SR was 59% [24]. On the 
other hand, Williams and colleagues observed 
sinus rhythm restoration in 78% of patients at 9 
months following surgery; however, the study 
included patients that had AF not lasting more 
than 6 months [25]. We could conclude in our 
study that sinus conversion rate was significantly 
lower in patients with a left atrial diameter over 
59mm. 
These findings were similar to most studies, in 
a study on 99 patients, Chen and collaborators 
claimed that sinus conversion rate was 
significantly lower in patients with a left atrial 
diameter over 56.8 mm [15]. In another study, a 
left atrial dimension of 51-60 mm was not 
associated with a lower rate of sinus conversion if 
compared to left atrial diameters below 50 mm, 
but atrial dimensions of more than 60 mm were 
associated with a 9-fold higher risk of failure at 1-
year follow-up [16]. 
There was a statistical significance between 
pre-operative AF duration and SR restoration. In 
the sinus group, mean AF duration in patients that 
regained SR at 6 months was 35.24 ± 11.47 months 
and in patients who were still in AF was 82.87 ± 
9.61 months. These findings suggest that post-
operative atrial fibrillation is also most likely 
affected by the duration of disease, as patients 
with shorter pre-operative disease duration are 
less vulnerable in retuning to atrial fibrillation post 
operatively. Yet, further investigation is 
recommended to investigate this finding. 
New York Heart Association heart failure 
Classification (NYHA) class did not seem to be a 
strong predictor of success or failure as. We did 
not experience any of the described procedure-
related complications except for one patient who 
presented with a first-degree heart block for 3 
days after the procedure and then reverted back 
to sinus rhythm. In our study, we reported a 
number of patients presenting with first-degree 
atrioventricular block or nodal rhythm in the 
immediate and early post-operative period, but  
The Egyptian Cardiothoracic Surgeon 
29 
Table 3: Kaplan-Meier Survival function estimates 
they all transitioned into sinus rhythm upon 
assessment at one week and/or at one month 
post-operatively. 
There were no reported cases of stroke or 
mortality in our study, which could be explained 
by the relatively young mean age of patients. 
However, in a study on 285 patients, in-hospital 
mortality was 4.2% (12 patients) and post-
operative stroke was reported 6 patients (2.1%) 
[26]. Ad and colleagues reported a low incidence 
of embolic stroke (6 patients out of 373) despite 
cessation of oral anticoagulation at 12 months in 
the majority of them [27]. 
Reviewing study limitations 
We had limitations in our study, one of them 
was the small sample size, and that was due to the 
limited number of resources (probes). The other 
limitation was to judge whether we have reached 
the accurate trans-mural ablation, as it was 
somehow based on subjective judgment which 
varies from surgeon to another. For future studies, 
we recommend increasing the sample size, 
increasing the follow-up period and introducing a 
comparative group, while further investigating 
confounding risk factors, to have a more 
controlled environment in accessing the incidence 
rates of AF. 
Conclusion 
A significant higher rate of success was 
associated in treating patients with paroxysmal or 
persistent atrial fibrillation patients using radio 
frequency ablation, who have left atrial diameter 
less than 59.0 mm. This can potentially allow 
mitral valve repair patients to stop taking oral 
anticoagulation in the future as all benefits of 
elimination of AF will be achieved (improved 
hemodynamics, no palpitations, improvement of 
symptoms and avoiding complications of 
anticoagulation). 
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